QIAGEN
QGEN • NYSE
QIAGEN is a medical - diagnostics & research company in the healthcare sector trading on NYSE, led by CEO Thierry Bernard, with a market cap of $9.2B.
CEOThierry Bernard
Next Earnings
Upcoming earnings announcement for QIAGEN
Date
Wednesday, May 6, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.58
Revenue Estimate
$511.8M
Earnings History
Past 12 earnings reports for QIAGEN
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Q4 2025 | $0.62Est: $0.62 | 0.0% | $540.0MEst: $528.3M | +2.2% | — |
| Nov 4, 2025 | Q3 2025 | $0.61Est: $0.58 | +5.2% | $533.0MEst: $525.9M | +1.3% | — |
| Aug 5, 2025 | Q2 2025 | $0.60Est: $0.60 | 0.0% | $534.0MEst: $524.1M | +1.9% | — |
| May 7, 2025 | Q1 2025 | $0.55Est: $0.49 | +12.2% | $483.0MEst: $466.2M | +3.6% | — |
| Feb 5, 2025 | Q4 2024 | $0.63Est: $0.63 | 0.0% | $521.0MEst: $518.5M | +0.5% | — |
| Nov 6, 2024 | Q3 2024 | $0.59Est: $0.56 | +5.4% | $502.0MEst: $491.7M | +2.1% | — |
| Jul 31, 2024 | Q2 2024 | $0.57Est: $0.53 | +7.5% | $496.0MEst: $494.5M | +0.3% | — |
| Apr 29, 2024 | Q1 2024 | $0.47Est: $0.45 | +4.4% | $458.8MEst: $457.3M | +0.3% | — |
| Feb 6, 2024 | Q4 2023 | $0.57Est: $0.54 | +5.6% | $509.2MEst: $501.3M | +1.6% | — |
| Oct 30, 2023 | Q3 2023 | $0.52Est: $0.49 | +6.1% | $475.9MEst: $469.8M | +1.3% | — |
| Aug 8, 2023 | Q2 2023 | $0.53Est: $0.52 | +1.9% | $495.0MEst: $493.8M | +0.2% | — |
| May 3, 2023 | Q1 2023 | $0.53Est: $0.49 | +8.2% | $485.4MEst: $480.5M | +1.0% | — |